- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Amgen Inc+ Add to Watchlist
AMGN:US102.1800 USD 3.4500 3.27%
As of 20:10:00 ET on 05/20/2013.
Company Profile for Amgen Inc (AMGN)
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
Key Executives for Amgen Inc (AMGN)
|Robert A Bradway "Bob"Chairman/President/CEO||Jonathan M PeacockExec VP/CFO|
|Anthony C Hooper "Tony"Exec VP:Commercial Ops||Madhavan BalachandranExec VP:Operations|
|Sean E HarperExec VP:Rsch & Dev||Brian M McNameeSenior VP:Human Resources|
|David J ScottSenior VP/Secy/Gen Cnsl||Arvind SoodVP:Investor Relations|